IL-15 抗体 (AA 70-162) (PE)
Our Local Distributor
北京 101111
Quick Overview for IL-15 抗体 (AA 70-162) (PE) (ABIN8001911)
抗原
See all IL-15 (IL15) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 70-162
-
原理
- Anti-IL15 Antibody PE Conjugated
-
交叉反应 (详细)
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human IL15 recombinant protein (Position: D70-S162).
-
亚型
- IgG
-
-
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- IL-15 (IL15) (Interleukin 15 (IL15))
-
别名
- IL15
-
背景
-
Background: Interleukin (IL)-15 is a cytokine with the ability to stimulate the proliferation activity of Th1 and/or Th2 lymphocytes. This gene is mapped to human chromosome 4q31 by fluorescence in situ hybridization. IL-15 is a novel cytokine whose effects on T-cell activation and proliferation are similar to those of interleukin-2 (IL-2), presumably because IL-15 utilizes the beta and gamma chains of the IL-2 receptor. IL-15 can play a role in the initiation and outcome of acute and chronic rejection. Anti-IL-15 therapy in combination with classic immunosuppression therapy might be beneficial in the prevention of acute, and especially chronic, allograft rejection.
Gene Full Name: interleukin 15
-
基因ID
- 3600
-
UniProt
- P40933
-
途径
- JAK/STAT Signaling, Glycosaminoglycan Metabolic Process
抗原
-